Fig. 3From: Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patientsChanges in bone turnover markers from baseline to 6 and 12 months in the total patients (n = 114). ALP, alkaline phosphatase. A Bone-specific ALP (μg/L). B Serum osteocalcin (ng/ml). C Serum C-terminal telopeptide (ng/ml). D Urine N-telopeptide (nM BCE/mM creatinine)Back to article page